biospecimen_aliquot__bcr_aliquot_barcode	tcga-d8-a1y2-01a-11d-a159-09
biospecimen_aliquot__bcr_aliquot_uuid	9dbf62eb-0de7-4410-b44b-fdf59026d8e6
biospecimen_aliquot__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
biospecimen_aliquot__bcr_sample_barcode	tcga-d8-a1y2-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099054613
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.09
biospecimen_aliquot__date_of_shipment	2011-05-17
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	2
biospecimen_aliquot__plate_id	a159
biospecimen_aliquot__plate_row	e
biospecimen_aliquot__quantity	3.60
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.87
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-d8-a1y2-01a-11d
biospecimen_analyte__bcr_analyte_uuid	0b1970d2-f489-4009-bc15-ae79d0e790a7
biospecimen_analyte__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
biospecimen_analyte__bcr_sample_barcode	tcga-d8-a1y2-01a
biospecimen_analyte__concentration	0.18
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-d8-a1y2
biospecimen_diagnostic_slides__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-d8-a1y2-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	77451a0f-00fd-44a9-a0d0-cb7a39ce74cc
biospecimen_normal_control__bcr_patient_barcode	tcga-d8-a1y2
biospecimen_normal_control__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
biospecimen_portion__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
biospecimen_portion__bcr_portion_barcode	tcga-d8-a1y2-01a-11
biospecimen_portion__bcr_portion_uuid	53e4511a-cb04-413b-8646-cda2db3b50b0
biospecimen_portion__bcr_sample_barcode	tcga-d8-a1y2-01a
biospecimen_portion__date_of_creation	2011-04-07
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-d8-a1y2-01a-11d
biospecimen_protocol__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
biospecimen_protocol__bcr_sample_barcode	tcga-d8-a1y2-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
biospecimen_sample__bcr_sample_barcode	tcga-d8-a1y2-01a
biospecimen_sample__bcr_sample_uuid	4c6bdfb2-3438-4216-b76d-d87c386bfa96
biospecimen_sample__days_to_collection	65
biospecimen_sample__initial_weight	470
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-d8-a1y2.4acd42d6-9520-4dc6-bb40-9187a4d49981.pdf
biospecimen_sample__pathology_report_uuid	4acd42d6-9520-4dc6-bb40-9187a4d49981
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
biospecimen_shipment_portion__bcr_sample_barcode	tcga-d8-a1y2-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	4a0da6ed-16e6-4f14-8f18-0df68e63d002
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17k
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-d8-a1y2-01a-21-a17k-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
biospecimen_slide__bcr_sample_barcode	tcga-d8-a1y2-01a
biospecimen_slide__bcr_slide_barcode	tcga-d8-a1y2-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	9210964e-1f00-4cde-99b2-97662455f1a1
biospecimen_slide__image_file_name	tcga-d8-a1y2-01a-01-ts1.9210964e-1f00-4cde-99b2-97662455f1a1.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	0
biospecimen_slide__percent_tumor_cells	100
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-d8-a1y2
biospecimen_tumor_sample__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
clinical_drug__bcr_drug_barcode	tcga-d8-a1y2-d30087
clinical_drug__bcr_drug_uuid	8706f572-ab8c-430f-9761-2aefa63f375b
clinical_drug__bcr_patient_barcode	tcga-d8-a1y2
clinical_drug__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
clinical_drug__form_completion_date	2012-4-2
clinical_drug__pharmaceutical_therapy_drug_name	tamoxifen
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	66
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	20
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-d8-a1y2-f30086
clinical_follow_up__bcr_followup_uuid	960bda3c-dbb7-4271-aebe-9c28bf0353a4
clinical_follow_up__bcr_patient_barcode	tcga-d8-a1y2
clinical_follow_up__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-4-2
clinical_follow_up__last_contact_days_to	433
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	71
clinical_patient__ajcc_metastasis_pathologic_pm	mx
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right lower outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-d8-a1y2
clinical_patient__bcr_patient_uuid	c7d7a770-23c0-4310-ab48-1f6152dc2849
clinical_patient__birth_days_to	-26021
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	manual counting
clinical_patient__er_positivity_scale_other	>75%
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-6-9
clinical_patient__gender	female
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_positivity_method_text	venten
clinical_patient__her2_status_by_ihc	indeterminate
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	73
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	7
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	fine needle aspiration biopsy
clinical_patient__patient_id	a1y2
clinical_patient__pr_positivity_define_method	manual counting
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	d8
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-D8-A1Y2-01A-11D-A159-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-D8-A1Y2-01A-11D-A159-09.bed.meta
manually_curated__id	tcga-d8-a1y2-01a-11d-a159-09
manually_curated__md5sum	0e22bd88104c8f548a652e337c98aaa8
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	9dbf62eb-0de7-4410-b44b-fdf59026d8e6
manually_curated__tumor_tag	brca
